tiprankstipranks
Yubo International Biotech (YBGJ)
OTHER OTC:YBGJ
US Market

Yubo International Biotech (YBGJ) Income Statement

12 Followers

Yubo International Biotech Income Statement

Last quarter (Q4 2025), Yubo International Biotech's total revenue was $134.39K, a decrease of -746716.67% from the same quarter last year. In Q4, Yubo International Biotech's net income was $-136.51K. See Yubo International Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 22Dec 21Dec 20
Total Revenue
$ 134.39K$ 3.47K$ 104.28K$ 1.24M$ 1.35M
Gross Profit
$ 8.16K$ -209.28K$ 52.65K$ 820.65K$ 1.24M
Operating Expenses
$ 1.20M$ 1.56M$ 1.26M$ 2.36M$ 1.95M
Depreciation and Amortization
$ 167.58K$ 183.30K$ 27.54K$ 21.40K$ 13.06K
EBITDA
$ -1.02M$ -1.80M$ -1.18M$ -1.52M$ -698.74K
Operating Income
$ -1.19M$ -1.77M$ -1.21M$ -1.54M$ -711.80K
Other Income/Expenses
$ -243.00$ -211.87K$ 229.00$ 427.00$ -3.00
Pretax Income
$ -1.19M$ -1.98M$ -1.20M$ -1.54M$ -711.80K
Net Income
$ -1.08M$ -1.78M$ -1.20M$ -1.54M$ -711.80K
Per Share Metrics
Basic EPS
$ -0.01$ -0.01$ -0.01$ -0.01$ -0.01
Diluted EPS
$ -0.01$ -0.01$ -0.01$ -0.01$ -0.01
Weighted Average Shares Outstanding
139.64M 119.82M 118.72M 118.13M 118.18M
Weighted Average Shares Outstanding (Diluted)
139.64M 119.82M 118.72M 118.13M 118.18M
Currency in USD

Yubo International Biotech Earnings and Revenue History